Qatar Investment Authority

13D and 13G Filings

13D/G filings
13D on 3 securities, 13G on 10 securities
CIK
0001441449
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 3 securities · may seek to influence control
Global Business Travel Group, Inc. 13D/A
GBTG · 37890B100
0% 9/29/2026
Event 9/29/2026
West Bay BDC LLC 13D/A 97.1% 7/29/2026
Event 7/27/2026
5C Lending Partners Corp. 13D 17.7% 5/13/2026
Event 3/20/2026
Schedule 13G · 10 securities · passive
Aspen Neuroscience, Inc. 13G
044933109
6.7% 11/3/2026
Event 10/30/2026
Nanobiotix SA 13G/A
NBTX · 63009J107
7.0% 7/29/2026
Event 6/30/2026
Fluence Energy, Inc. 13G/A
FLNC · 34379V103
8.3% 5/19/2026
Event 5/15/2026
Sionna Therapeutics Inc 13G/A
SION · 829401108
4.5% 5/12/2026
Event 3/31/2026
BioXcel Therapeutics, Inc. 13G/A
BTAI · 09075P105
0.6% 3/30/2026
Event 12/31/2025
Perspective Therapeutics Inc 13G
CATX · 46489V302
6.2% 2/5/2026
Event 2/4/2026
Alignment Healthcare, Inc. 13G
ALHC · 01625V104
6.7% 9/24/2025
Event 9/17/2025
Vistra Corp 13G
VST · 92840M102
5.5% 8/5/2025
Event 6/30/2025
Establishment Labs Holdings Inc 13G/A
ESTA · G31249108
8.3% 5/13/2025
Event 3/31/2025
Lomond Therapeutics Holdings, Inc. 13G
54173L101
7.8% 3/26/2025
Event 3/24/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.